Indian equities extended gains for a third straight session, with Sensex and Nifty rising on optimism over the Iran-US peace framework and ...

The bond between US President Donald Trump and French President Emmanuel Macron began with a firm handshake but has since seen open disagre...

Indian stock markets experienced sharp losses for the third consecutive session, with Sensex and Nifty falling over 1% each. Escalating Ira...

Aurobindo Pharma stock is performing well. Sales in Europe are improving. New products are launching in the US. The company is also develop...

Medicines are vital but useless if lost or spoiled. Pharmaceutical logistics ensures their safe delivery. DHL's Florstadt campus near Frank...

New US tariffs on patented drugs will not significantly impact India. The country mainly exports affordable generic medicines to America. T...

Indian drug maker Sun Pharma faces significant exposure to potential US tariffs on medicines. Global brokerage Jefferies warns that while g...

The biggest debate on price cuts is happening in the US with patients, insurers and the government joining in.

Drug companies say that they are not objecting to the control of healthcare costs, but it is the high-handed approach that is harming the i...

Bahr advocating stronger cooperation between Indian and Germany in the health sector, especially in immigration of medical and nursing prof...

'There will be a significant growth in top-line and the company will participate in more tenders in Germany to mitigate the margin erosion.'

Indian pharmaceutical companies are reworking their strategies for Europe to cope with the intense pressure on drug prices because of chang...

The bid is scheduled to open in the first week of November. Germany, which is the world’s second largest drug market, looks for ways to cur...

Leading Indian drug makers with a large presence in Germany could face substantial pressure on margins following a recent tender by a Germa...

While pricing pressure both in the US and Europe is leading to lower profitability, companies are also suffering the impact of firmer rupee...

Dr Reddy’s Laboratories (DRL) aims to shift production of about a dozen top-selling products of its German arm Betapharm to India by July 2...

A year-old acquisition in Germany has turned out to be a white elephant for Torrent Pharmaceuticals after the German government introduced ...